Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
133.00
-2.44 (-1.80%)
Jul 23, 2026, 9:30 AM EDT - Market open
Protagonist Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens JMP | Citizens JMP | Buy Maintains $137 → $165 | Buy | Maintains | $137 → $165 | +24.06% | Jul 17, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $121 | Buy | Maintains | $121 | -9.02% | Jul 16, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 16, 2026 |
| Barclays | Barclays | Buy Maintains $119 → $151 | Buy | Maintains | $119 → $151 | +13.53% | Jul 14, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $97 → $110 | Hold | Maintains | $97 → $110 | -17.29% | Jun 11, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $106 → $113 | Buy | Maintains | $106 → $113 | -15.04% | May 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $117 | Buy | Reiterates | $117 | -12.03% | May 11, 2026 |
| Citi | Citi | Buy Maintains $125 → $130 | Buy | Maintains | $125 → $130 | -2.26% | May 10, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.